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Abstract
Background: While global maternal mortality declined 44 % between 1990 and 2015, the majority of countries fell
short of attaining Millennium Development Goal targets. The Sustainable Development Goals (SDGs), adopted
in late 2015, include a target to reduce national maternal mortality ratios (MMR) to achieve a global average
of 70 per 100,000 live births by 2030. A comprehensive paper outlining Strategies toward Ending Preventable
Maternal Mortality (EPMM) was launched in February 2015 to support achievement of the SDG global targets.
To date, there has not been consensus on a set of core metrics to track progress toward the overall global maternal
mortality target, which has made it difficult to systematically monitor maternal health status and programs over time.
Findings: The World Health Organization (WHO), Maternal Health Taskforce (MHTF), and the US Agency for
International Development (USAID) along with its flagship Maternal and Child Survival Program (MCSP), facilitated
a consultative process to seek consensus on maternal health indicators for global monitoring and reporting
by all countries. Consensus was reached on 12 indicators and four priority areas for further indicator development and
testing. These indicators are being harmonized with the Every Newborn Action Plan core metrics for a joint global
maternal newborn monitoring framework. Next steps include a similar process to agree upon indicators to monitor
social, political and economic determinants of maternal health and survival highlighted in the EPMM strategies.
Conclusion: This process provides a foundation for the maternal health community to work collaboratively to track
progress on core global indicators. It is important that actors continue to work together through transparent
and participatory processes to track progress to end preventable maternal mortality and achieve the SDG
maternal mortality targets.
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Background
In September 2015, the era of the Millennium Develop-
ment Goals (MDGs) came to an end, and while the world-
wide maternal mortality ratio (MMR) declined by 44 %
from 1990 to 2015, the global target of a 75 % reduction
was not reached. In fact, the majority of countries fell
short of attaining MDG5 targets for maternal mortality re-
duction. Maternal mortality remains unacceptably high
with approximately 303,000 maternal deaths occurring
each year, with the largest burden in Sub-Saharan Africa
and Asia [1].
Beginning in January 2013, the Ending Preventable
Maternal Mortality (EPMM) Working Group, led by the
World Health Organization (WHO) with support from
partner organizations, achieved multi-stakeholder con-
sensus on goals for maternal health and survival from
2015 to 2030.
The EPMM targets for maternal mortality reduction at
the global and country levels are:
 By 2030, the global average maternal mortality ratio
(MMR) should be less than 70 maternal deaths per
100,000 live births
 By 2030, every country should reduce its maternal
mortality ratio by at least two thirds from 2010
baseline, and no country should have a ratio higher
than 140 deaths per 100,000 live births (twice the
global target)
 All countries are tasked with achieving equity in
MMR among sub-populations
A comprehensive paper outlining the Strategies toward
Ending Preventable Maternal Mortality (EPMM) was re-
leased by WHO in February 2015 [2]. This was followed
by a synthesis of priorities for ending preventable mater-
nal and newborn deaths and stillbirths in a series of
technical papers in support of the updated United
Nations Global Strategy for Women’s, Children’s, and
Adolescent’s Health (2016–2030) [3].
The EPMM global MMR target was incorporated into
the Sustainable Development Goals (SDGs) adopted by
member states and launched in late 2015 [4]. The SDGs
form the basis of a new global development agenda,
which is broad and comprehensive, covering a wide
range of social, economic and environmental goals. The
EPMM global target was also included in the updated
UN Global Strategy.
To achieve the ambitious SDG and Global Strategy
MMR targets, it will be imperative to accelerate coverage
of quality essential services and to address the underlying
social, political and economic determinants of maternal
health across all settings. To support implementation of
EPMM strategies and to track progress toward global
and country MMR targets, consensus on priority,
methodologically robust maternal health (MH) indica-
tors is urgently needed. To this end, in May 2015,
the EPMM Working Group specified a plan to de-
velop a comprehensive maternal health global moni-
toring and reporting framework in two phases:
1) Phase 1: Consensus on a core set of priority,
methodologically robust maternal health indicators
with direct relevance for reducing preventable
mortality (proximal to causes of death) for global
monitoring and reporting by all countries
2) Phase 2: Consensus on complementary indicators to
track progress toward addressing the social, political
and economic determinants of maternal health and
survival (distal to causes of death) highlighted in the
global EPMM strategy for testing by countries as part
of national health plans and monitoring frameworks
This paper describes the process and results of
Phase I – to develop a core set of maternal health in-
dicators for global monitoring and reporting by all
countries. This core set of maternal health indicators
will be harmonized with Every Newborn Action Plan
(ENAP) core metrics to create a joint global maternal
and newborn monitoring framework [5].
Methods
The World Health Organization, Maternal Health
Taskforce (MHTF), and the US Agency for Inter-
national Development (USAID) along with its flagship
Maternal and Child Survival Program (MCSP), facilitated
an iterative consultative process to reach consensus on a
core set of maternal health indicators for global monitor-
ing and reporting under Phase I on behalf of the EPMM
Working Group. Key phases of the process led by an
EPMM-designated steering committee included: (1) struc-
tured mapping exercise to identify indicators for monitor-
ing and evaluation of maternal health; (2) development of
key principles, criteria, and consultative process for selec-
tion of EPMM phase I indicators; (3) selection of experts/
stakeholders to participate in consultative process in line
with agreed criteria; (4) facilitation of a series of virtual
consultations via webinar, phone and in writing to rank
and prioritize indicators based on a set of pre-determined
questions and criteria; and (5) an in-person one-day tech-
nical meeting with identified experts/stakeholders to reach
consensus on a core set of MH indicators for global moni-
toring (Fig. 1).
The EPMM-designated steering committee included
six persons selected to represent a range of expertise, in-
cluding technical, policy and measurement experts, who
were tasked with overseeing the process of defining a
core set of global maternal health indicators (Table 1).
The Steering Committee identified four principles to
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guide development and prioritization of a set of core
MH indicators for global monitoring and reporting.
First, the scope was limited to priority indicators ap-
propriate for global monitoring and reporting by all
countries. It was agreed that the primary purpose of
the indicators would be to track progress toward ma-
ternal mortality reduction at the global level, with no
more than 10 to 12 indicators in total. It was ac-
knowledged that complementary (and sometimes
overlapping) indicators would be needed to support
effective program management at sub-national and
service delivery levels but that these indicators were
beyond the scope of the EPMM global indicator exer-
cise. During the process, indicators for other levels of
monitoring and reporting were systematically captured
and recorded for future research and development, build-
ing on numerous ongoing indicator development efforts.
A second guiding principle was to limit Phase I indicators
to measures directly linked to the proximal causes of ma-
ternal death to mirror the core set of newborn health
metrics outlined in the Every Newborn Action Plan.
More distal determinants, such as social, economic,
political, and health systems factors, will be developed
under Phase II of the EPMM process.
The third agreed principle was to use the same
organizational categories of these ENAP metrics, to fa-
cilitate a harmonized global maternal and newborn
monitoring framework. Thus it was agreed to retain the
ENAP metrics organizational categories of impact,
coverage and input indicators. Finally, it was assumed
Fig. 1 Process for Consensus Building, August-October, 2015
Table 1 Steering Committee Membersa
Name Organization Job title Training, area of expertise
Allisyn Moran, PhD MHS US Agency for International
Development
Senior Maternal Health Advisor Monitoring and evaluation, research,
maternal and child health
R. Rima Jolivet, CNM, DrPH Maternal Health Task Force Maternal Health Technical Director Certified nurse-midwife, public health,
maternal health system strengthening,
quality improvement
Kathleen Hill, MD Maternal and Child Survival
Program, Jhpiego
Team Lead, Maternal Health Family physician, public health, service
delivery, program implementation,
quality improvement
Barbara Rawlins, MPH Maternal and Child Survival
Program, Jhpiego
Team Lead, Monitoring and Evaluation Monitoring and evaluation, research,
maternal and child health
Lale Say, MD World Health Organization,
Department of Reproductive
Health and Research
Coordinator, adolescents and at-risk
populations
Reproductive Health and Research
Physician, monitoring and evaluation,
research, program strengthening
Sarah Dalglish, PhD World Health Organization,
Department of Reproductive
Health and Research
Consultant Political Economy, International
Relations, Health Politics and Policy
Kate Ramsey, MPH,
DrPH (c) (position at the
time of this project)
Averting Maternal Death and
Disability Program, University
of Columbia
Senior Research Officer Public health, maternal and newborn
health service delivery, health systems,
implementation research
aNo financial conflicts declared by any members of the Steering Committee
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that indicators would be reported at least every 5 years
to track progress toward global targets.
In parallel, the steering committee finalized indicator
selection criteria, drawing from criteria used in other in-
dicator prioritization activities (e.g. WHO 100 core indi-
cators [6]). Selection criteria included: (1) relevance for
directly reducing preventable mortality; (2) validity
(measures what it is supposed to measure); (3) feasibility
(feasible to measure routinely through household sur-
veys, health facility assessments, routine information sys-
tems); (4) degree of data availability across countries;
and (5) strengthens or complements existing monitoring
frameworks (MDGs, SDGs; ENAP; and other global ef-
forts (e.g. Global Strategy for Women's, Children's, and
Adolescent's Health; WHO Quality of Care Initiative,
etc.)). The WHO indicator mapping exercise (phase one
above) included searching online databases, reviewing
program documents and other global monitoring frame-
works, and discussions with implementing partners
and donor agencies. An initial expert consultation
was conducted in May 2015. Applying these princi-
ples and selection criteria, the Steering Committee
compiled the indicators prioritized during this consult-
ation, as well as priority indicators for tracking SDGs, and
other indicator mapping efforts. This list was refined and
updated, which resulted in a final list of 20 to 25
indicators.
In the second phase a series of virtual consultations
was conducted with selected expert participants. Key
stakeholders and experts were identified through review
of participant lists from other indicator/measurement
consultations, discussions with the broader EPMM
Working Group, and other relevant stakeholders. The
focus was on identifying participants who work directly
in measurement of maternal health including clinicians,
researchers, program implementers, global policy makers
and representatives from Ministries of Health, UN agen-
cies, and donors. (Table 2). Based on the structured indi-
cator review and input from measurement experts, the
Steering Committee developed key questions related to
the underlying principles and indicator selection criteria
to guide discussion and feedback during a series of
virtual consultations. In each virtual technical review
session, the indicators were discussed, guided by the
key questions. Feedback from previous sessions was
also shared, so learnings were incorporated and re-
fined during successive phases. Written feedback was
solicited from those unable to participate in planned
consultations.
To culminate the consultation process, an in-person
meeting was held in Washington, DC in mid-September
2015, bringing together a broader group of experts. The
meeting was convened by the Maternal and Child
Survival Program with financial support from the US
Agency for International Development (USAID). Some
participants were supported through funding from
other institutions and development partners. This in-
person consultation was guided by the same key
questions addressed in previous virtual session. Dur-
ing the in-person meeting, participants considered the
results from the first rounds of feedback to deliberate
and reach consensus on a final core set of maternal
health indicators for global monitoring and reporting.
The in-person one-day consultation also addressed
commonly perceived gaps in maternal health indica-
tors, proposals for additional indicators and other is-
sues raised by participants. Inputs from all steps of
the consultation (virtual, written and in-person) were
compiled in a matrix summarizing feedback and main
discussion points (Additional file 1). A report of the
in-person consultation highlighting the main discus-
sion points was also developed.
Results
In total, 45 experts from 11 countries participated in one
or more stages of the structured consultative process to
reach consensus on a core set of maternal health indica-
tors for global monitoring and reporting. The experts
agreed on 12 maternal health indicators - three impact,
seven coverage, and two input indicators (Table 3). Five
indicators overlap with the Every Newborn Action Plan
core metrics, six indicators overlap with the WHO list of
100 core indicators, and one indicator overlaps with the
WHO 2013 Quality of MNCH care indicators [5–7]
(Table 3; Additional file 2). The definitions, disaggrega-
tors, and data sources to accompany the Core Maternal
Health Indicators for Global Monitoring and Reporting
have been finalized (Table 4). Four areas were prioritized
for further research and testing, namely content of ante-
natal care, content of postpartum care, respectful mater-
nity care, and Met Need for Emergency Obstetric Care
(EmOC).
The group was unanimous in its consensus to deliver
this core set of maternal health indicators to WHO for
further member state consultation and deliberation
through global processes, including harmonization with
core metrics from the ENAP and consideration as part
of a combined monitoring framework for maternal and
newborn health within the Indicator Framework of the
Global Strategy for Women’s, Children’s and Adoles-
cents’ Health (2016–2030).
Consensus was reached through extensive discussion
of all proposed indicators (see Table 5). The final core
list of indicators focuses primarily on routine care for all
women; however, ending preventable maternal death re-
quires appropriate management of maternal complica-
tions. The group discussed two potential composite
indicators related to essential services for obstetric
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complications- Unmet Obstetric Need (UON: the pro-
portion of women who receive surgery/major obstetric
intervention among all women who experience a severe
complication that is an indication for surgery/major ob-
stetric intervention) and Met Need for Emergency Ob-
stetric Care (the proportion of women who are expected
to experience a complication who receive treatment) [8,
9]. Neither indicator met all the selection criteria for in-
clusion, due to issues related to feasibility and validity.
For example, Met Need for EmOC assumes 15 % of
women will experience a complication; this denominator
has not been validated and may vary by setting. UON as-
sumes 1 to 2 % of women will experience a severe com-
plication, which has been validated in several settings.
However the UON numerator is based on obstetric
complications requiring surgical interventions which can
be variable even for a single complication (e.g. pre-
eclampsia/eclampsia (PEE) or postpartum hemorrhage
(PPH) can often be managed without surgical interven-
tion.) [9]. The group agreed that Met Need for EmOC
was more appropriate for global monitoring, but that
further refinement of the denominator would be needed
for inclusion in a global monitoring framework. It was
agreed that countries that are currently collecting Met
Need for EmOC should continue to monitor this indica-
tor at national and sub-national levels until the indicator
has been updated.
There was widespread agreement on the need to refine
the skilled birth attendant (SBA) indicator to increase its
validity. WHO and UNICEF are working in this area to re-
view and revise the current metadata and enhance meas-
urement (personal communication, Chou and Amouzou),
and the indicator met other inclusion criteria. Therefore,
SBA was included in the core MH indicator list, with in-
stitutional delivery added as a supplemental indicator.
There were also important discussions about how to inter-
pret caesarean section rates, given the global ongoing de-
bates about the appropriate population-based proportion
and rising rates of voluntary caesarean sections. It was
agreed that it will be particularly important for this indica-
tor to be disaggregated by residence and socio-economic
quintile, and increasingly to capture indications [10]. The
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group discussed a measure to indicate the availability of
functional EmOC facilities. Some participants felt this
indicator needed further refinement prior to inclusion,
especially to re-define the denominator to be based on
expected pregnancies/births instead of population. Ul-
timately, the group agreed that this indicator met the
criteria for global monitoring and that the definition
would be updated moving forward.
Particular areas of contention included whether mea-
sures of facility-level quality of care and coverage are use-
ful and feasible for global monitoring and reporting (e.g.
measures of specific content of antenatal, labor and deliv-
ery, and postpartum care). While many participants
agreed that such measures are critically needed for pro-
gram improvement and effectiveness at country level,
there was a lack of consensus on whether or not quality
measures should be included in a global monitoring
framework as well as active debate about which indicator
would adequately capture all elements of care. A single in-
dicator for routine labor and delivery care—provision of
uterotonic immediately after birth—was selected. In
addition, the group strongly agreed on the importance of
a high-level indicator of provision of respectful maternity
care (RMC) and elimination of mistreatment in childbirth
[11]. There was agreement that such metrics need further
development and testing prior to inclusion for global
monitoring and reporting. The development of indicators
related to quality of antenatal care, postnatal care, RMC
and Met Need for EmOC were flagged as an important
priority for further development and testing. The group
acknowledged ongoing work by WHO to define quality of
care indicators for maternal and newborn care in health
facilities as part of the WHO Quality of Care framework.
Discussion
“What gets measured gets done.” This simple phrase
captures the synergistic relationship between measure-
ment and action [12], which is critical for achieving am-
bitious targets outlined in EPMM Strategy documents,
the SDGs, and the UN Global Strategy for Women’s,
Children’s, and Adolescent’s Health. This paper describes
the results and process of defining core maternal health
Table 3 Core Maternal Health Indicators for Global Monitoring and Reporting
Indicator Priority areas for indicator development
Impact 1. Maternal mortality ratioa c
2. Maternal cause of death (direct/indirect)
based on ICD-MM
3. Adolescent birth ratec
COVERAGE: care for all women and girls 4. Four or more antenatal care visitsc Content of antenatal careb
5. Skilled attendant at birtha c Content of postnatal care
6. Institutional delivery Respectful maternity careb
7. Early postnatal/postpartum care for woman
and baby (within 2 days of birth)a c
8. Met need for family planningc
9. Uterotonic immediately after birth for prevention
of post-partum hemorrhage (among facility births)b
COVERAGE: care for women and
girls with complications
10. Caesarean section ratea Met need for Emergency Obstetric Care
INPUTS: counting 11. Maternal death registration
INPUT: Availability of care 12. Availability of functional Emergency Obstetric
Care facilitiesa
aENAP indicator
bLink to WHO Quality of Care metrics
cLink to WHO 100 Core indicators
NOTES:
- WHO will propose a definition for maternal death registration
- Availability of functional emergency obstetric care facilities requires additional definition - The current definition will be used in the short term, with ongoing
efforts to improve definition (both numerator and denominator)
- Countries should continue to monitor met need for emergency obstetric are and update definitions once they are finalized based on ongoing work
- Additional priority indicators – Efforts will link with ongoing efforts such as WHO Antenatal Care Guideline revision process, WHO Quality of Care Initiative,
Global Strategy for Women’s, Children’s, and Adolescent Health
- Currently, antenatal and postnatal care are measured through the number of contacts with the health system (as defined as “visits”), but the quality or content
of these visits are not assessed. Two of the priority areas moving forward include defining core content for these antenatal and postnatal visits as well as
measures to assess those the core content areas
- Content of antenatal care could include: blood pressure, testing and treatment of infectious disease, counseling on danger signs, testing for HIV/AIDS,
prevention of malaria during pregnancy, birth planning, etc. Content of postpartum care could include: monitoring bleeding, counseling for family planning,
observing breastfeeding, counseling and assessment of postpartum depression, etc
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Table 4 Core Maternal health indicators for global monitoring and reporting – definitions and data sources
Indicator Definition Numerator Denominator Disaggregation Data Source(s)
Impact Maternal Mortality
Ratioa c
Death from any cause related
to or aggravated by pregnancy
or its management (excluding
accidental or incidental causes)
during pregnancy, childbirth or
within 42 days of termination of
pregnancy, per 100,000 live births
for a specified time period
Number of maternal
deaths
Per 100,000 live births
in the same period







Deaths from any cause related or
aggravated by pregnancy or its
management (excluding accidental
or incidental causes) during
pregnancy, childbirth or within 42
days of termination of pregnancy




Total number of maternal
deaths in the same period






Number of births to women 15 to
19 years of age per 1,000 women
within specified time period
Number of births to
women 15 to 19 years
of age
Per 1,000 women 15 to
19 years of age in the
same period





Four or more ANC
visitsc
Proportion of pregnant women
and girls who have made at least
four antenatal care visits within
specified time period
Number of women
and girls who received
ANC at least four times
during pregnancy
Total number of women
and girls with a live birth








Proportion of births attended by
skilled health personnel (doctor,
nurse, midwife) within a specified
time period
Number of live births
attended by skilled
health personnel
Total number of live






Institutional delivery Proportion of births in a health
facility within a specified time
period
Number of live births
in a health facility
Total number of live










Proportion of women and girls
who gave birth in a facility
receiving oxytocin immediately
after birth within a specified
time period
Number of women
and girls who gave




and girls with a facility







(within 2 days of birth)a c
Proportion of women/girls with a
recent birth and their babies who
received postnatal care within two
days of birth (regardless of place
of delivery) within a specified
time period
Number of women/girls
and their babies who
received postnatal care
within two days of
childbirth
Total number of women/
girls with a last live birth



















Table 4 Core Maternal health indicators for global monitoring and reporting – definitions and data sources (Continued)
Met need for family
planningc
Proportion of women and girls,
either married or in a union, who
have their need for contraception
satisfied within a specified time
period
Number of women
and girls who have
their need for
contraception satisfied
Total number of women
and girls, married or in














Proportion of women and girls
with a live birth delivered by




Total number of live
births to women and






INPUT: counting Maternal death
registration, including
cause of deatha
Proportion of maternal deaths
registered with cause of death
specified based on ICD-MM




cause of death specified
based on ICD-MM codes
Total estimated number
of maternal deaths in
the same time period








At least five emergency obstetric
care facilities (per 500,000 people)
including at least one comprehensive
and the rest basic emergency
obstetric care facilities.
Number of obstetric care
facilities that provided
EmOC signal functionsd
in the last three months






bLink to WHO Quality of Care metrics
cLink to WHO 100 Core Indicators
dSignal functions; Basic: 1) parenteral antibiotics; 2) uterotonic drugs; 3) parenteral anticonvulsants for preeclampsia and eclampsia; 4) manual removal of placenta; 5) remove retained products (e.g. manual vacuum
extraction, dilation and curettage); 6) perform assisted vaginal delivery (e.g. vacuum extraction, forceps delivery); and 7) basic neonatal resuscitation (e.g., with bag and mask); Comprehensive: All seven basic plus: 8)














Table 5 Maternal Health Indicators considered for global monitoring and reporting, by indicator selection criteria
Indicator Criteria (√ = YES, ~ = Some, X = No) Notes
Relevance Validity Feasibility Availability Complements MH
Monitoring FWa
Impact
Maternal mortality ratio √ √ ~ ~ √
Maternal cause of death √ ~ ~ ~ √ - Global Strategy indicator – need to
strengthen information systems to
routinely collect
Case fatality rate √ ~ ~ ~ X - More feasible to collect at sub-national
or service delivery levels
Adolescent birth rate √ √ √ √ √
COVERAGE: care for all women and girls
4 or more antenatal care visits √ √ √ √ √
Blood pressure screening during
antenatal care
√ √ √ √ X - May focus ANC on only BP screening
Full course of iron/folate during
pregnancy
√ X √ √ X - May focus ANC on only iron folate
Skilled attendant at birth √ ~ √ √ √ - SDG indicator
Institutional delivery √ √ √ √ X - Complements skilled attendant at birth
Oxytocin within 1 minute of birth
(facility births)
√ ~ ~ ~ X - Indicates quality of delivery care
- Feasible to strengthen routine health
information systems to collect
- Timing is challenging
- Change wording to “uterotonic
immediately after birth”
Companion at birth √ ~ X X X - Respectful maternity care important,
but this is only one element
- May focus respectful maternity care
only on companion at birth
- Not feasible for many high-volume
facilities
- Not included in large-scale household
surveys
Early postpartum care for woman √ ~ √ √ √ - Postnatal/postpartum care within 2 days
of birth, regardless of place of delivery
Met Need for family planning √ √ √ √ √
COVERAGE: Care for women and girls with complications
Caesarean section rate among
poor (bottom two quintiles)
√ √ ~ ~ X
Caesarean section rate √ √ √ √ √
Met need for EmOC √ X X X X
UnMet need for EmOC √ X X X X
INPUT: counting
Birth registration X ~ ~ ~ √ - Not relevant for maternal mortality –
included in ENAP core metrics
Death registration, including
cause of death
√ ~ ~ ~ √
INPUT: Availability of care
Availability of EmOC per 500,000
population
√ ~ ~ ~ X - Essential to include an indicator on
emergency obstetric care – indicator to
be refined and updated
Indicators in italics NOT included in final core list
NOTE: √ = YES; ~ = Some; X = No
aSDGs, WHO 100 Core indicators, WHO Quality of Care metrics, Every Newborn Action Plan (ENAP)
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indicators for global monitoring and reporting as part of
the EPMM strategy. Agreement on a core set of global
maternal health indicators is important for galvanizing
action and accountability to reduce preventable ma-
ternal mortality as well as to highlight technical areas
needing further development and indicator testing.
WHO will propose the agreed indicators for further
member state consultation through global processes,
including harmonization with Every Newborn Action
Plan core metrics into a combined global monitoring
framework for maternal and newborn health. All par-
ticipants pledged their support for these processes.
The MDG5 goals and targets raised the profile of global
maternal mortality reduction, galvanizing political will and
resource allocation, which contributed to accelerated pro-
gress in mortality reduction. Between 1990 and 2000,
MMR declined at an estimated average annual rate of
1.2 % globally, compared with an average of 3.0 % between
2005 and 2015 after the launch of the Millennium Devel-
opment Goals in 2000 [1]. But accelerating further de-
clines and ensuring equity will now require different
strategies and concerted efforts to reach vulnerable and
at-risk populations. A common global monitoring frame-
work that includes key coverage and outcome indicators
will be crucial to monitor whether strategies are working
as intended to track progress toward global targets.
The core maternal health indicators are the result of a
systematic sequential process to prioritize a small num-
ber of impact, coverage and input measures for global
monitoring. These global indicators are not intended to
address the measurement needs and priorities for im-
provement at all levels of the system across all contexts.
Other complementary efforts are underway to address
maternal and newborn health measurement needs related
to processes and outcomes at national, subnational and
service delivery levels. The core global level indicators
complement these other measurement efforts and con-
tribute to policy decision-making, resource mobilization,
program planning, and aim to accountability for achieving
preventable maternal deaths across the globe.
There has been promising progress in defining, testing
and using indicators to monitor maternal health programs
at subnational and service-delivery levels [13–15]. The
global indicator on availability of functional EmOC facil-
ities will build on this existing body of work to incorporate
elements of basic maternity care, newborn care, human
resources, travel time, and others. In addition, WHO is
leading an initiative to define standards and metrics for
quality of facility-based care around the time of birth. The
WHO quality of care framework and associated metrics
prioritize measures for use by managers and providers to
drive improvements in maternal and newborn care at the
point of service [16]. In collaboration with the ENAP met-
rics improvement plan, work is underway to validate
several facility-based indicators, including the Phase I
EPMM indicator uterotonic use immediately after birth.
This validation work will include assessing whether the
woman was aware that a uterotonic was given after birth
to prevent postpartum hemorrhage.
There are also many efforts underway to develop and
test innovative methods to generate higher quality data
to more accurately track facility-level quality of care
metrics routinely. Innovative approaches around com-
bining population-based surveys and health facility sur-
veys are in progress [17, 18] as well as unique methods
for routine monitoring of signal functions for obstetric
and newborn care through quarterly monitoring visits
(personal communication, UNFPA). Furthermore, there
are efforts underway to use geographic information sys-
tems (GIS) to capture access to care and visualize data
at sub-national levels to improve decision making [19].
As these methods are tested and refined, they will greatly
contribute to more robust and accurate data to track pro-
gram implementation and outcomes, which can be uti-
lized at sub-national and service delivery levels to improve
quality of care, and ultimately feed into global level moni-
toring and reporting. To allow for evolving improvements
in measurement strategies and data quality, the global
monitoring framework must be dynamic and flexible to
incorporate new developments and indicators.
There were some limitations. First, because the goal
was to reach expert consensus on technically sound indi-
cators for monitoring progress toward global maternal
health goals, the timeframe was dictated by time-bound
global political processes, including the launch of the
SDGs and the Global Strategy. As a result, it was not
possible to conduct a lengthy process utilized in other
indicator prioritization exercises or research studies.
However, every attempt was made to follow a systematic
and transparent process, including a series of virtual
consultations with experts from diverse backgrounds
based on pre-determined principles, indicator selection
criteria, and standard questions, which culminated with
an in-person meeting. This process provided a transpar-
ent mechanism for consensus-building, within the time
constraints. In total, over 45 stakeholders participated in
the process; however, there were limited participants
from the country level. WHO will conduct further con-
sultations with member states through global processes,
and the core MH indicators from this process have been
introduced into consultations regarding indicator selec-
tion for the UN Global Strategy for Women’s, Children’s
and Adolescent’s Health.
Second, to meet the aim of a core set of indicators ac-
ceptable for global monitoring and reporting by all
countries, the issues of feasibility, such as current data
availability and quality, were by necessity balanced
against the desire to “push the envelope” and drive
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accelerated health information system improvements.
The group attempted to deal with this tension openly in
the discussions and some indicators that will require fur-
ther refinement and testing were included for this reason
while others were not. For example, maternal cause of
death is included as a core indicator, although further
work is needed to standardize diagnosis, coding, and
promote recording of all deaths.
Finally, monitoring the core set of indicators for mater-
nal health cannot be implemented without attention
to data systems and efforts to ensure adequate data qual-
ity. We must support countries in developing and imple-
menting plans to routinely collect these indicators
through existing data systems and surveys, such as na-
tional health management information systems, household
survey programs such as Demographic and Health Sur-
veys (DHS) or Multiple Indicator Cluster Surveys (MICS),
and health facility assessments such as the Service Avail-
ability and Readiness Assessment (SARA), the Service
Provision Assessment (SPA), and not create parallel struc-
tures. The recently launched Health Data Collaborative is
working to coordinate investments and build capacity at
country level to collect indicators required for SDG
monitoring.
The global Strategies toward Ending Preventable Ma-
ternal Mortality [2] highlights an overall call to improve
metrics, measurement systems and data quality. Repre-
senting one among several essential components of that
goal, a core set of global indicators is key to galvanizing
action and prioritizing attention to maternal health and
survival, driving investment in the improvement of ser-
vices, delivery systems and other proximal determinants,
and providing a mechanism for accountability to stake-
holders. The next phase of this process aims to develop
consensus on measures to address the more distal causes
of maternal survival and health, drawing from the key
objectives in EPMM strategic framework that focus on
the underlying social, political, and economic determi-
nants of maternal health and survival, providing a path-
way for countries to operationalize the EPMM strategic
objectives and measure change over time.
The SDGs are intended to realize the rights of all and
to achieve gender equality and the empowerment of
women and girls, balancing the dimensions of sustain-
able development: the economic, social, and environ-
mental [20]. The UN Secretary General’s Global Strategy
for Women’s, Children’s, Adolescent’s Health addresses
health across sectors and SDGs to move beyond the
focus on survival to thriving and transformation. The In-
dicator and Monitoring Framework for the Global Strat-
egy describes 16 key indicators considered the minimal
subset of a total of 60 indicators to provide assessment
of progress towards the implementation of the Global
Strategy objectives [21]. The EPMM Phase I indicators
maternal mortality ratio and adolescent birth rate are in-
cluded within this minimum dataset, however expanded
monitoring of outcomes related to the key themes of
EPMM will help to fully realize and address priority is-
sues in the SDGs, including equity, human resources,
gender, and human rights. Taken together, the develop-
ment of the EPMM Phase I and II indicators will track
progress and address a comprehensive set of issues re-
lated to not only “survival” but also “thrive and trans-
form”; together they track progress.
Conclusion
Within the global maternal health community, there has
been a lack of consensus on core metrics for monitoring
maternal health status, health system performance and
program implementation necessary to achieve EPMM tar-
gets. This is largely due to the complex nature of maternal
health programs that must address a wide range of health
determinants and deliver a package of services across a
continuum within the context of differing political prior-
ities, health system structures, and in coordination with
non-health sector actors. However, the lack of robust mea-
sures, functioning measurement systems, and data of reli-
able quality have stymied efforts to accurately track
whether countries are meeting global health targets. It is
important that members of the global and maternal health
communities work together through participatory pro-
cesses to track progress at all levels (global, regional,
national, subnational, and facility) to end preventable ma-
ternal mortality. This paper describes a core set of
maternal health indicators for global monitoring and
reporting for all countries, developed through an inclusive,
iterative, and consultative process led by WHO on behalf
of the EPMM Working Group. Monitoring these core in-
dicators will be critical to support achievement of the glo-
bal targets outlined in the SDGs and ultimately to end
preventable maternal mortality.
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